InvestorsHub Logo
Followers 116
Posts 1882
Boards Moderated 0
Alias Born 11/22/2017

Re: meirluc post# 206933

Sunday, 01/06/2019 7:34:12 PM

Sunday, January 06, 2019 7:34:12 PM

Post# of 709714

However, it occurred to me that perhaps the 2 year survival figure of 46.2% recorded at 3/17 was a derived figure that was based on performance up to 3/17 and predicted the final 2 year survival percentage of the entire trial. In that case, a projection of a 65%-70% survival at 2 years for the last 54 patients could have been factored in and they ended up being only off by 0.2% (46.2% vs. 46.4%)



Meirluc,

Right!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News